Thus, to improve the detection efficiency of SARS-CoV-2 NAT, we highly recommend: 1) sampling as close to symptom onset as possible for initial diagnosis of COVID-19; 2) consecutively sampling 2–3 respiratory specimens with at least one LRT specimen if missing early stages of COVID-19. The gene discussed is BRD2; the disease is COVID-19.